Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−7.14 USD
−61.23 M USD
7.16 M USD
4.49 M
About Assembly Biosciences, Inc.
Sector
CEO
Jason A. Okazaki
Headquarters
South San Francisco
Website
Founded
2005
FIGI
BBG000R62Q06
Assembly Biosciences, Inc. is a biotechnology company, which engages in the development of products for infectious diseases, such as chronic hepatitis B virus and illnesses associated with a dysbiotic microbiome. It focuses on two innovative platform programs: oral therapeutics for the treatment of hepatitis B virus, and the oral synthetic live biotherapeutics candidate. The company was founded by Uri Lopatin and Derek A. Small on October 7, 2005 and is headquartered in South San Francisco, CA.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of ASMB is 16.83 USD — it has increased by 2.63% in the past 24 hours. Watch Assembly Biosciences, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Assembly Biosciences, Inc. stocks are traded under the ticker ASMB.
ASMB stock has fallen by −4.64% compared to the previous week, the month change is a −10.32% fall, over the last year Assembly Biosciences, Inc. has showed a 97.54% increase.
We've gathered analysts' opinions on Assembly Biosciences, Inc. future price: according to them, ASMB price has a max estimate of 36.00 USD and a min estimate of 35.00 USD. Watch ASMB chart and read a more detailed Assembly Biosciences, Inc. stock forecast: see what analysts think of Assembly Biosciences, Inc. and suggest that you do with its stocks.
ASMB reached its all-time high on May 9, 2011 with the price of 1,260.00 USD, and its all-time low was 7.69 USD and was reached on Nov 22, 2023. View more price dynamics on ASMB chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
ASMB stock is 10.62% volatile and has beta coefficient of 0.95. Track Assembly Biosciences, Inc. stock price on the chart and check out the list of the most volatile stocks — is Assembly Biosciences, Inc. there?
Today Assembly Biosciences, Inc. has the market capitalization of 96.62 M, it has decreased by −8.80% over the last week.
Yes, you can track Assembly Biosciences, Inc. financials in yearly and quarterly reports right on TradingView.
Assembly Biosciences, Inc. is going to release the next earnings report on Mar 6, 2025. Keep track of upcoming events with our Earnings Calendar.
ASMB earnings for the last quarter are −1.51 USD per share, whereas the estimation was −2.30 USD resulting in a 34.44% surprise. The estimated earnings for the next quarter are −1.97 USD per share. See more details about Assembly Biosciences, Inc. earnings.
Assembly Biosciences, Inc. revenue for the last quarter amounts to 6.84 M USD, despite the estimated figure of 5.77 M USD. In the next quarter, revenue is expected to reach 5.20 M USD.
ASMB net income for the last quarter is −9.61 M USD, while the quarter before that showed −11.15 M USD of net income which accounts for 13.80% change. Track more Assembly Biosciences, Inc. financial stats to get the full picture.
No, ASMB doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 28, 2024, the company has 65.00 employees. See our rating of the largest employees — is Assembly Biosciences, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Assembly Biosciences, Inc. EBITDA is −46.26 M USD, and current EBITDA margin is −896.22%. See more stats in Assembly Biosciences, Inc. financial statements.
Like other stocks, ASMB shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Assembly Biosciences, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Assembly Biosciences, Inc. technincal analysis shows the strong buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Assembly Biosciences, Inc. stock shows the neutral signal. See more of Assembly Biosciences, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.